Medicare Part B drugs: trends in spending and utilization, 2008-2021

Medicare Part B drugs: trends in spending and utilization, 2008-2021

Collection:
Health Policy and Services Research
Series Title(s):
ASPE issue brief and Inflation Reduction Act research series
Author(s):
Nguyen, Nuguyen X., author
Olsen, T. Anders, author
Sheingold, Steven, author
De Lew, Nancy, author
Contributor(s):
United States. Department of Health and Human Services. Office of the Assistant Secretary for Planning and Evaluation, issuing body.
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, June 9, 2023
Language(s):
English
Format:
Text
Subject(s):
Cost Control
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicare Part B -- economics
United States
United States.
Genre(s):
Technical Report
Abstract:
Over the 2008-2021 period, Medicare fee-for-service (FFS) Part B drug spending per enrollee grew on average at 9.2 percent annually. This spending growth was more than triple the rate in Part D (2.6 percent) and nearly 4 times as high as the rate of per capita annual prescription drug spending across all payers (2.4 percent).a The Inflation Reduction Act (IRA) includes several new provisions designed to address the rapid rate of increase in Part B drug spending and lower costs for Medicare enrollees.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
Extent:
1 online resource (1 PDF file (21 pages))
Illustrations:
Illustrations
NLM Unique ID:
9918697331606676 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/9918697331606676